John L. Brottem - 18 Apr 2022 Form 4 Insider Report for Outset Medical, Inc. (OM)

Role
General Counsel
Signature
John L Brottem
Issuer symbol
OM
Transactions as of
18 Apr 2022
Net transactions value
-$81,552
Form type
4
Filing time
18 Apr 2022, 19:34:16 UTC
Previous filing
17 Mar 2022
Next filing
17 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OM Common Stock Options Exercise $9,480 +1,000 +2.9% $9.48 35,014 18 Apr 2022 Direct
transaction OM Common Stock Sale $43,249 -1,000 -2.9% $43.25 34,014 18 Apr 2022 Direct F1, F2
transaction OM Common Stock Options Exercise $13,414 +1,415 +4.2% $9.48 35,429 18 Apr 2022 Direct
transaction OM Common Stock Sale $61,197 -1,415 -4% $43.25 34,014 18 Apr 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OM Non-Qualified Stock Option (right to buy) Options Exercise $0 -1,415 -3.6% $0.000000 38,223 18 Apr 2022 Common Stock 1,415 $9.48 Direct F3
transaction OM Performance Options (right to buy) Options Exercise $0 -1,000 -31% $0.000000 2,265 18 Apr 2022 Common Stock 1,000 $9.48 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 12, 2021.
F2 The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $42.00-$42.99 - 672 shares; $43.00-$43.99 - 1,743 shares. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 This option vests 25% on May 26, 2021 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date.
F4 In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.